Endexx Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EDXC research report →
Companywww.endexx.com
Endexx Corporation engages in the manufacturing and sale of cannabidiol (CBD)-based products for the health and wellness market. It provides CBD creams, oils, capsules, extracts, topicals, drinks, chocolates, and pet products, as well as hemp-derived health and beauty care products for supporting the therapeutic relief of pain and inflammation for humans and pets through its e-commerce site cbdunlimited. com, as well as other online and in-store retailers.
- CEO
- Todd A. Davis
- IPO
- 2001
- Employees
- 10
- HQ
- Cave Creek, AZ, US
Price Chart
Valuation
- Market Cap
- $57.19K
- P/E
- -0.00
- P/S
- 0.09
- P/B
- -0.00
- EV/EBITDA
- -1.39
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 53.36%
- Op Margin
- -22.92%
- Net Margin
- -1885.35%
- ROE
- 47.97%
- ROIC
- 0.82%
Growth & Income
- Revenue
- $1.66M · -57.64%
- Net Income
- $-3,397,330 · 47.72%
- EPS
- $-0.01 · 49.61%
- Op Income
- $-583,388
- FCF YoY
- 72.18%
Performance & Tape
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.50
- Avg Volume
- 80.47K
Get TickerSpark's AI analysis on EDXC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our EDXC Coverage
We haven't published any research on EDXC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EDXC Report →